Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry.

Kato, T A; Yamauchi, Y; Horikawa, H; Monji, A; Mizoguchi, Y; Seki, Y; Hayakawa, K; Utsumi, H; Kanba, S

Kato, T A; Yamauchi, Y; Horikawa, H; Monji, A; Mizoguchi, Y; Seki, Y; Hayakawa, K; Utsumi, H; Kanba, S.

Affiliation

Kato TA; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan. takahiro@npsych.med.kyushu-u.ac.jp

Curr Med Chem ; 20(3): 331-44, 2013.

Article in En | MEDLINE | ID: mdl-23157624

Subject(s)

Mental Disorders/drug therapy; Microglia/drug effects; Neurotransmitter Agents/pharmacology; Psychiatry; Psychotropic Drugs/pharmacology; Animals; Humans; Microglia/metabolism; Neurotransmitter Agents/chemistry; Psychotropic Drugs/chemistry

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psychiatry / Psychotropic Drugs / Microglia / Neurotransmitter Agents / Mental Disorders Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2013 Document type: Article Affiliation country: Japan Country of publication: United Arab Emirates

Search on Google

Add to My VHL

XML

PubMed Links